TrialBreast cancer (Tokyo, Japan)2025

Impact of modified dexamethasone administration sequence on infusion reaction incidence in HER2-positive breast cancer: a randomized multicenter trial.

Ryoichi Matsunuma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.